These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29170667)

  • 1. Will a mAb-Based Immunotherapy Directed against Cancer Stem Cells Be Feasible?
    Santamaria S; Delgado M; Kremer L; Garcia-Sanz JA
    Front Immunol; 2017; 8():1509. PubMed ID: 29170667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
    Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
    Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
    Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
    Singh SP; Singh R; Gupta OP; Gupta S; Brahma Bhatt ML
    J Oncol; 2020; 2020():3963561. PubMed ID: 32211043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
    Xu M; Yuan Y; Xia Y; Achilefu S
    Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against human cancer stem cells.
    Naujokat C
    Immunotherapy; 2014; 6(3):290-308. PubMed ID: 24762074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells: A Review of Recent Advances.
    Ertas YN; Abedi Dorcheh K; Akbari A; Jabbari E
    Nanomaterials (Basel); 2021 Jul; 11(7):. PubMed ID: 34361141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
    Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
    Parte SC; Batra SK; Kakar SS
    J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model.
    Al Faraj A; Shaik AS; Ratemi E; Halwani R
    J Control Release; 2016 Mar; 225():240-51. PubMed ID: 26827662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
    Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
    Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ever-changing landscape of pancreatic cancer stem cells.
    Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B
    Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.